Linagliptin 5mg + Dapagliflozin 10mg Tablets

Linagliptin 5mg + Dapagliflozin 10mg is a combination of two antidiabetic medicines used to control blood sugar levels in adults with type 2 diabetes mellitus. Dapagliflozin helps remove excess sugar through urine, while linagliptin increases insulin release after meals and lowers glucagon levels. This treatment is for type 2 diabetes and is not used for type 1 diabetes or diabetic ketoacidosis. Drink enough fluids and watch for symptoms of urinary infection, genital infection, dehydration, or low blood sugar, especially if used with insulin or a sulfonylurea.
Take Linagliptin 5mg + Dapagliflozin 10mg once daily or as advised by the doctor. Keep the diet, activity, and glucose-monitoring plan recommended for diabetes.
Dapagliflozin removes excess glucose through urine. Linagliptin increases meal-related insulin release and reduces glucagon, helping lower blood sugar.
Common side effects include urinary tract infection, genital fungal infection, increased urination, thirst, nausea, and low blood sugar when combined with insulin or sulfonylureas. Severe dehydration, ketoacidosis symptoms, or pancreatitis symptoms need urgent care.
Review kidney function, hydration, urine/genital infection history, pancreatitis, fasting or surgery plans, pregnancy, breastfeeding, insulin, sulfonylureas, diuretics, and ketone symptoms.
Type 2 diabetes mellitus in adults.
Helps lower blood sugar through two complementary actions and supports long-term diabetes control when used with diet, exercise, and monitoring.
Linagliptin 5mg + Dapagliflozin 10mg is used to control blood sugar levels in adults with type 2 diabetes mellitus.
Dapagliflozin removes excess sugar in urine, while linagliptin improves meal-related insulin response and lowers glucagon.
Low blood sugar is more likely if it is taken with insulin or sulfonylureas.
Burning urination, fever, genital itching, discharge, or pain should be reported to the doctor.
No. It is used for type 2 diabetes and is not a treatment for diabetic ketoacidosis.
Linagliptin dapagliflozin, DPP 4 SGLT2 combination, Urinary glucose excretion, Type 2 diabetes dual therapy, Ketoacidosis warning, Genital infection risk, AR: Linagliptin + Dapagliflozin أقراص, FR: Linagliptin + Dapagliflozin comprimé, PT: Linagliptin + Dapagliflozin comprimido, ES: Linagliptin + Dapagliflozin tableta, RU: Linagliptin + Dapagliflozin таблетки, ID: Linagliptin + Dapagliflozin, VI: Linagliptin + Dapagliflozin viên nén, MS: Linagliptin + Dapagliflozin, TL: Linagliptin + Dapagliflozin tableta, ZH-SG: Linagliptin + Dapagliflozin 片剂
International B2B Enquiry
Send a structured B2B enquiry for Linagliptin 5mg + Dapagliflozin 10mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Linagliptin 5mg + Dapagliflozin 10mg Tablets